Patents
Patents for C07H 21 - Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids (89,892)
04/2009
04/23/2009WO2008138658A3 Pharmaceutical compounds comprising abasic oligonucleotides
04/23/2009WO2008090417A3 Inhibition of nf-kb
04/23/2009WO2008088301A3 Inhibitors of dnaa activity
04/23/2009WO2008062310A3 Elimination of the bacteria that cause pierce's disease
04/23/2009WO2008028044A9 Markers and methods for assessing and treating ulcerative colitis and related disorders using 66 gene panel
04/23/2009WO2007144886A3 Virus-like particles for treatment of viral infections
04/23/2009WO2007086889A3 Tropoelastin isoforms and uses thereof
04/23/2009WO2007056218A3 Heparan sulfate glycosaminoglycan lyase and uses thereof
04/23/2009WO2007053719A3 Chemically cleavable 3'-o-allyl-dntp-allyl-fluorophore fluorescent nucleotide analogues and related methods
04/23/2009WO2007047741A3 Expression of rbap48 in memory and aging and methods related thereto
04/23/2009WO2007044839A3 Glutamate 2,3-aminomutases and methods of use thereof
04/23/2009WO2007041511A3 Hematopoietic progenitor kinase 1 for modulation of an immune response
04/23/2009WO2007041213A3 Methods for regulation of p53 translation and function
04/23/2009WO2007028121A3 Eg8798 and eg9703 polynucleotides and uses thereof
04/23/2009WO2007025079A3 Detection of mutations in a gene associated with resistance to viral infection, oas2 or oas3
04/23/2009WO2007014075A3 Rnai modulation of the rho-a gene in research models
04/23/2009WO2007005645A3 Materials and methods for the generation of fully 2'-modified nucleic acid transcripts
04/23/2009WO2007001487A3 Modulation of negative immune regulators and applications for immunotherapy
04/23/2009WO2006135886A3 Compositions and methods for treating and diagnosing cancer
04/23/2009WO2006133333A3 Stimulation of pancreatic b cell proliferation
04/23/2009WO2006116455A3 System for genetic surveillance and analysis
04/23/2009WO2006116407A3 Compositions and methods for spinocerebellar ataxia
04/23/2009WO2006113671A3 Methylation markers for diagnosis and treatment of cancers
04/23/2009WO2006112879A3 Hunk, a snf1-related kinase essential for mammary tumor metastasis
04/23/2009WO2006104891A3 Methods and genetic constructs for modification of lignin composition of corn cobs
04/23/2009WO2006081192A3 Rnai modulation of the nogo-l or nogo-r gene and uses thereof
04/23/2009WO2006035434A3 Oligoribonucleotides and methods of use thereof for treatment of alopecia, acute renal failure and other diseases
04/23/2009WO2006001888A3 Compositions and methods for inhibiting angiogenesis
04/23/2009WO2005103279A3 Synthetic genes
04/23/2009WO2005097205A3 Dna virus microrna and methods for inhibiting same
04/23/2009WO2005089443A3 Combinatorial methods and compositions for treatment of melanoma
04/23/2009WO2005077084A3 Krüppel-like transcriptional factor klf4/gklf and uses thereof
04/23/2009WO2005032399A3 Il4 receptor antagonists for horse, dog and cat
04/23/2009US20090106867 Red lettuce
04/23/2009US20090106866 Promoter, Promoter Control Elements, And Combinations, And Uses Thereof
04/23/2009US20090106863 Overexpression of Starch Synthase in Plants
04/23/2009US20090106860 nucleotide sequences for a stress-induced promoter endogenously associated with the rye CBF31 coding region; transforming a plant cell to comprise the sequence operably linked to a regulatory sequence of the present invention; regulates transcription and is induced in response to abiotic stress
04/23/2009US20090106859 Root-Preferred Regulatory Elements
04/23/2009US20090106858 Isolation and Characterization of the Csb3-1 Mutant of Arabidopsis Thaliana and Use Thereof as a Regulator of Resistance in Plants to Diseases Caused by Biotrophic Pathogens
04/23/2009US20090106852 Influenza Therapeutic
04/23/2009US20090105467 Antisense oligonucleotide constructs based on beta-arabinofuranose and its analogues
04/23/2009US20090105454 Prophylactic/therapeutic agent for cancer
04/23/2009US20090105450 Use of modified metal oxides for enrichment of phosphopeptides
04/23/2009US20090105294 Biosynthetic Gene Cluster for the Production of a Complex Polyketide
04/23/2009US20090105178 RNA INTERFERENCE MEDIATED INHIBITION OF PLATELET-DERIVED ENDOTHELIAL CELL GROWTH FACTOR (ECGF1) GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA)
04/23/2009US20090105177 Modulation of diacylglycerol acyltransferase 1 expression
04/23/2009US20090105176 Methods and Compositions for the Treatment of Eye Disorders with Increased Intraocular Pressure
04/23/2009US20090105175 Methods and Compositions for the Treatment of Eye Disorders with Increased Intraocular Pressure
04/23/2009US20090105174 Nucleic acids hybridizable to micro rna and precursors thereof
04/23/2009US20090105173 Prevention and treatment of acute renal failure and other kidney diseases by inhibition of p53 by siRNA
04/23/2009US20090105172 Stabilized Aptamers to PSMA and Their Use as Prostate Cancer Therapeutics
04/23/2009US20090105170 Multiple Heat Shock Elements
04/23/2009US20090105169 Allele-specific silencing of disease genes
04/23/2009US20090105150 Angiotensin derivatives
04/23/2009US20090105140 Albumin Fusion Proteins
04/23/2009US20090105116 Polypeptide Ligands Containing Linkers
04/23/2009US20090105115 Polyamides for nucleic acid delivery
04/23/2009US20090105090 Phage Display By Novel Filamentous Bacteriophage
04/23/2009US20090105082 Non-invasive molecular colony methods, kits and apparatus
04/23/2009US20090104703 Nucleic Acids Encoding Proteins Involved in Sensory Transduction
04/23/2009US20090104693 a gene encoding the blood group Pk (Gb3) synthase, termed alpha 4Gal-T1, probes to the DNA encoding alpha 4Gal-T1, DNA constructs comprising DNA encoding alpha 4Gal-T1
04/23/2009US20090104681 Polypeptides Having Alpha-Amylase and Granular Starch Hydrolyzing Activity
04/23/2009US20090104668 Method for Producing Biopterins Using Tetrahydrobiopterin Biosynthesis Enzyme
04/23/2009US20090104662 Use of interleukin-4 antagonists and compositions thereof
04/23/2009US20090104659 DNA encoding the aldolase; culturing to produce a protein having aldolase activity; Arthrobacter
04/23/2009US20090104658 Heterologous Production of Capreomycin and Generation of New Capreomycin Derivatives Through Metabolic Engineering
04/23/2009US20090104657 Lipase Production Method
04/23/2009US20090104648 Transgenic cell models comprised of osmosensing histidine kinase for use in identifying fungicides; polynucleotide encoding the kinase; drug screening
04/23/2009US20090104623 Compositions for controlling hair growth
04/23/2009US20090104621 Method for detecting a target nucleic acid sequence
04/23/2009US20090104619 Human G-Protein Coupled Receptors
04/23/2009US20090104616 Primer set for amplifying sult1a1 gene, reagent for amplifying sult1a1 gene containing the same, and the uses thereof
04/23/2009US20090104614 Quantitative molecular probes
04/23/2009US20090104613 Methods and compositions relating to multiplexed genomic gain and loss assays
04/23/2009US20090104612 Detection of blood group genes
04/23/2009US20090104610 Real-Time Multiplex Detection of Three Bacterial Species Responsible for Sexually Transmitted Diseases
04/23/2009US20090104608 EUBACTERIAL tmRNA SEQUENCES AND USES THEREOF
04/23/2009US20090104607 EUBACTERIAL tmRNA SEQUENCES AND USES THEREOF
04/23/2009US20090104606 Late gestation lung genes, fragments and uses thereof
04/23/2009US20090104604 Sperm-specific cation channel, catsper2, and uses therefor
04/23/2009US20090104599 Genetic variant of the annexin a5 gene
04/23/2009US20090104232 Yersina virulence antigen specific monoclonal antibody for use in prevention of plague; prevention of bioterrorism; directed protein evolution
04/23/2009US20090104218 Group B Streptococcus
04/23/2009US20090104208 House Dust Mite Allergen
04/23/2009US20090104204 Human Binding Molecules Having Killing Activity Against Staphylococci and Uses Thereof
04/23/2009US20090104203 Compositions and Methods for Regulating Osteoclast Differentiation, Activation and Bone Resorption
04/23/2009US20090104199 Breast Cancer Resistance Protein (BCRP) And The DNA Which Encodes It
04/23/2009US20090104196 for modulating the activity of the lysine-specific demethylase (LSD1) in a mammal; for identifying a patient having high risk prostate carcinomas
04/23/2009US20090104190 Humanized anti-cd4 antibody with immunosuppressive properties
04/23/2009US20090104187 Novel Rabbit Antibody Humanization Methods and Humanized Rabbit Antibodies
04/23/2009US20090104186 Melanoma-associated MHC class I associated oligopeptides and the uses thereof
04/23/2009US20090101506 Method, specific primers and kit for the detection of neisseria meningitidis
04/23/2009DE102008050273A1 Vorrichtung und Verfahren zum Synthetisieren eines Biopolymers und Verfahren zum Wiedergewinnen eines Reagens zum Synthetisieren eines Biopolymers Apparatus and method for synthesizing a biopolymer and method for recovering a reagent for synthesizing a biopolymer
04/22/2009EP2050035A2 Methods for identifying, diagnosing, and predicting survival of lymphomas
04/22/2009EP2049691A2 Crohn disease susceptibility gene
04/22/2009EP2049665A2 Dinucleotide mrna cap analogs
04/22/2009EP2049559A2 Improved vaccines and methods for using the same
04/22/2009EP2049158A2 Controlling osteogenesis by inhibition of osteogenic suppressors
04/22/2009EP1940860A4 Methods and compositions for identifying biomarkers useful in diagnosis and/or treatment of biological states
04/22/2009EP1567672B1 Expression profiling based on histocultures